Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity upon House Dust Mite Skin Challenge in Patients Suffering from Moderate to Severe Atopic Dermatitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs ANB 020 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacodynamics; Proof of concept
- Sponsors AnaptysBio
- 10 Aug 2017 Status changed from recruiting to active, no longer recruiting, according to an AnaptysBio media release.
- 08 Mar 2017 According to an AnaptysBio media release, status changed from planning to recruiting.
- 04 Mar 2017 According to AnaptysBio media release, top line data from this study are anticipated during the second half of 2017.